WuXi NextCODE Stock
Using genomic information to improve health
Sign up today and learn more about WuXi NextCODE Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About WuXi NextCODE Stock
WuXi NextCODE is a fully integrated contract genomics organization building the global standard platform for genomic data. With offices in Shanghai; Kendall Square in Cambridge, Massachusetts; and Reykjavik, Iceland, we serve the leading population genomics, precision medicine, diagnostics and wellness initiatives and enterprises using the genome to improve health around the world. Our capabilities span study design, sequencing, secondary analysis, storage, and interpretation and scalable analytics – all backed by the most proven and widely used technology for organizing, mining and sharing genome sequence data. We are also applying the same capabilities to advance a growing range of sequence-based tests and scans in China. WuXi NextCODE is a WuXi Group company.
Hannes Thor Smárason
President and Chief Scientific Officer